These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11958391)

  • 1. Three cases of digital ischemia successfully treated with cilostazol.
    Dean SM; Satiani B
    Vasc Med; 2001 Nov; 6(4):245-8. PubMed ID: 11958391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cilostazol on resting ankle pressures and exercise-induced ischemia in patients with intermittent claudication.
    Mohler ER; Beebe HG; Salles-Cuhna S; Zimet R; Zhang P; Heckman J; Forbes WP
    Vasc Med; 2001; 6(3):151-6. PubMed ID: 11789969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful pharmacologic treatment of lower extremity ulcerations in 5 patients with chronic critical limb ischemia.
    Dean SM; Vaccaro PS
    J Am Board Fam Pract; 2002; 15(1):55-62. PubMed ID: 11841139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL; Cutler BS; Meissner MH; Strandness DE
    Circulation; 1998 Aug; 98(7):678-86. PubMed ID: 9715861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cilostazol on arterial wound healing: a retrospective analysis.
    Resnick KA; Gordon IL
    Ann Vasc Surg; 2014 Aug; 28(6):1513-21. PubMed ID: 24561209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
    Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
    Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism.
    Biscetti F; Pecorini G; Straface G; Arena V; Stigliano E; Rutella S; Locatelli F; Angelini F; Ghirlanda G; Flex A
    Int J Cardiol; 2013 Aug; 167(3):910-6. PubMed ID: 22473072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol and peripheral arterial disease.
    Pearce L; Ghosh J; Counsell A; Serracino-Inglott F
    Expert Opin Pharmacother; 2008 Oct; 9(15):2683-90. PubMed ID: 18803454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol increases skin perfusion pressure in severely ischemic limbs.
    Miyashita Y; Saito S; Miyamoto A; Iida O; Nanto S
    Angiology; 2011 Jan; 62(1):15-7. PubMed ID: 20504836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
    Money SR; Herd JA; Isaacsohn JL; Davidson M; Cutler B; Heckman J; Forbes WP
    J Vasc Surg; 1998 Feb; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interims analysis of a prospective observational study on the use of cilostazol (Pletal®) in daily clinical vascularsurgical practice].
    Meyer F; Graf D; Weber M; Panteli B; Adolf D; Halloul Z
    Zentralbl Chir; 2011 Oct; 136(5):436-43. PubMed ID: 22009542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF; Davie AM; Clegg JP
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication.
    Smith JA
    Clin Cardiol; 2002 Mar; 25(3):91-4. PubMed ID: 11892686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
    Hong H; Mackey WC
    Clin Ther; 2014 Aug; 36(8):1290-301. PubMed ID: 25012728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cilostazol (Pletal) in the management of intermittent claudication.
    Bradbury AW
    Int J Clin Pract; 2003 Jun; 57(5):405-9. PubMed ID: 12846346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of withdrawal of drugs treating intermittent claudication.
    Dawson DL; DeMaioribus CA; Hagino RT; Light JT; Bradley DV; Britt KE; Charles BE
    Am J Surg; 1999 Aug; 178(2):141-6. PubMed ID: 10487267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication.
    Soga Y; Yokoi H; Kawasaki T; Nakashima H; Tsurugida M; Hikichi Y; Nobuyoshi M
    J Am Coll Cardiol; 2009 Jan; 53(1):48-53. PubMed ID: 19118724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol: treatment of intermittent claudication.
    Reilly MP; Mohler ER
    Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute ischemia of the fingers].
    Gouet O; Hautefort E; Iselin F
    Ann Chir Main; 1989; 8(4):352-5. PubMed ID: 2596899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol treatment of claudication in diabetic patients.
    Rendell M; Cariski AT; Hittel N; Zhang P
    Curr Med Res Opin; 2002; 18(8):479-87. PubMed ID: 12564659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.